About Peptinovo Biopharma
Peptinovo Biopharma is a private company based in Ann Arbor, Michigan. It has reported $2,252,885 raised in two offerings on Form D since June 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | Sep 24, 2024amended Dec 16, 2024 | $1,297,885of $10.0M target | 12 | $108K | EquityRule 506(c) | Form D/A ↗1 earlier filing |
| Jun 7, 2021 | Jun 21, 2021 | $955,000target not set | 12 | $79,583 | Options, SIMPLE AGREEMENTS FOR FUTURE EQUITYRule 506(b) | Form D ↗ |
| Total, two offerings | $2,252,885 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Peptinovo Biopharma's Form D filed Dec 16, 2024.
DR
David Romenesco
Director
FB
Fred Brown
Director
RH
Reynold Homan
President and director
BE
Bill Elliott
Executive officer
ST
Steve Tokaz
Executive officer and director